EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biopharmaceutical company developing non-antibiotic, topical antimicrobial products, today ...
NovaBay Pharmaceuticals, Inc., an advanced clinical-stage biopharmaceutical company developing anti-microbial products, today announced positive top-line results from its recently completed Phase 2 ...
Please provide your email address to receive an email when new articles are posted on . A trial of a gold-tipped contact force-sensing catheter for treatment of patients with atrial flutter met its ...
Citric acid 6.602g, glucono-delta-lactone 198mg, magnesium carbonate 3.177g; per 100mL; irrigation soln (pH 3.85). Dissolution of renal or bladder calculi composed of apatite or struvite in select ...
UMED Inc. (CEO Steve Myungchan Park) has drawn attention as the preclinical research results of its world-first automated intermittent bladder irrigation system, UroRinse, were published in the ...
Thirty-six patients with unsatisfactory treatment of neurogenic bowel dysfunctions (NBD) were enrolled from Spinal Units and Rehabilitation Centers in Italy. Treatment was for 3 weeks using a newly ...
Hosted by the Consumer Technology Association (CTA), CES is the world's largest technology and innovation event, featuring more than 3,000 global companies annually. The CES Innovation Awards ...
Bi-directional catheters provide improved maneuverability and new shaft design allows for better handling ST. PAUL, Minn., St. Jude Medical, Inc., a global medical device company, announced today that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback